{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:00:11Z","timestamp":1791165611001,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The increasing number of patients with refractory angina pectoris, combined with the aging population and improved survival rates among coronary heart disease patients, presents a significant challenge in contemporary cardiovascular medicine. The treatment of refractory angina has been an ongoing area of exploration, yet a comprehensive analysis of the existing literature on this topic is currently lacking. Therefore, this study aims to provide the first bibliometric analysis of publications related to refractory angina.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search was conducted in the Web of Science database to identify articles related to refractory angina published between 2003 and 2022. The inclusion criteria were limited to articles and reviews written in English. CiteSpace software was utilized to conduct a collaborative network analysis of countries\/regions, institutions and authors, co-occurrence analysis of keywords, and co-citation analysis of authors and references.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1,386 publications were identified, with an annual publication volume exhibiting fluctuation over time. American and European countries and institutions demonstrated a leading position in terms of research output. Henry TD emerged as the most prolific researcher in the field, while Mannheimer C received the highest number of citations. The primary research hotspot within this field focused on the treatment of refractory angina, with recent emphasis on emerging treatments such as stem cell therapy and the coronary sinus reducer. A significant number of clinical trials have been conducted, with a continuous focus on patient benefits, quality of life, and survival prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Significant progress has been made in the field of refractory angina pectoris in recent years. Novel treatment methods, including spinal cord stimulation, enhanced external counterpulsation, stem cell therapy, and the coronary sinus reducer, hold promising therapeutic prospects. However, further high-quality evidence-based research is essential to support these emerging interventions. Additionally, the development of comprehensive evidence-based guidelines for refractory angina treatment is crucial. Such guidelines would provide clinicians with a framework to navigate the complexities of treatment choices and optimize patient care in this challenging condition.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1228201","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T21:49:52Z","timestamp":1692913792000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Refractory angina pectoris: a 20-year (2003\u20132022) bibliometric analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Yunru","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Huan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojie","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pharmthera.2016.03.008","article-title":"Pharmacological approaches of refractory angina","volume":"163","author":"Giannopoulos","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.recesp.2010.11.015","article-title":"El stent reductor del seno coronario para el tratamiento de la angina de pecho refractaria cr\u00f3nica [the coronary sinus reducer stent for the treatment of chronic refractory angina pectoris]","volume":"64","author":"Paz","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e001287","DOI":"10.1161\/JAHA.114.001287","article-title":"Predictors of long-term clinical endpoints in patients with refractory angina","volume":"4","author":"Povsic","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijcard.2018.06.116","article-title":"Safety and efficacy of the reducer: a multi-center clinical registry\u2014REDUCE study","volume":"269","author":"Giannini","year":"2018","journal-title":"Int J Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jcin.2018.01.251","article-title":"Coronary sinus reducer implantation for the treatment of chronic refractory angina: a single-center experience","volume":"11","author":"Giannini","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.4244\/EIJ-D-18-01180","article-title":"Technical aspects in coronary sinus reducer implantation","volume":"15","author":"Giannini","year":"2020","journal-title":"EuroIntervention"},{"key":"B9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM199909303411402","article-title":"Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease","volume":"341","author":"Frazier","year":"1999","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/s0140-6736(98)11478-2","article-title":"Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial","volume":"353","author":"Schofield","year":"1999","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199909303411403","article-title":"Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina","volume":"341","author":"Allen","year":"1999","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American heart association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","volume":"34","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s0140-6736(99)08113-1","article-title":"Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC investigators. Angina treatments-lasers and normal therapies in comparison","volume":"354","author":"Burkhoff","year":"1999","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/s0735-1097(00)00519-2","article-title":"Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial","volume":"35","author":"Aaberge","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, autologous CD34+ cell therapy for refractory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nrcardio.2013.200","article-title":"Treatment of refractory angina in patients not suitable for revascularization","volume":"11","author":"Henry","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.cir.0000047041.66447.29","article-title":"Committee on the management of patients with chronic stable angina. ACC\/AHA 2002 guideline update for the management of patients with chronic stable angina\u2013summary article: a report of the American college of cardiology\/American heart association task force on practice guidelines (committee on the management of patients with chronic stable angina)","volume":"107","author":"Gibbons","year":"2003","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/hrt.2006.100784","article-title":"Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study","volume":"93","author":"Eddicks","year":"2007","journal-title":"Heart"},{"key":"B22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/eurheartj\/ehx486","article-title":"The reducer device in patients with angina pectoris: mechanisms, indications, and perspectives","volume":"39","author":"Konigstein","year":"2018","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","article-title":"The RENEW trial: efficacy and safety of intramyocardial autologous CD34(+) cell administration in patients with refractory angina","volume":"9","author":"Povsic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.cjca.2011.07.007","article-title":"Management of patients with refractory angina: canadian cardiovascular society\/Canadian pain society joint guidelines","volume":"28","author":"McGillion","year":"2012","journal-title":"Can J Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2261-9-13","article-title":"Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials","volume":"9","author":"Taylor","year":"2009","journal-title":"BMC Cardiovasc Disord"},{"key":"B26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/euhj.2001.2706","article-title":"The problem of chronic refractory angina; report from the ESC joint study group on the treatment of refractory angina","volume":"23","author":"Mannheimer","year":"2002","journal-title":"Eur Heart J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s12471-016-0862-2","article-title":"Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: a single-centre real-world experience","volume":"24","author":"Abawi","year":"2016","journal-title":"Neth Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/eurheartj\/ehaa820","article-title":"Management of refractory angina: an update","volume":"42","author":"Davies","year":"2021","journal-title":"Eur Heart J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur Heart J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions","volume":"39","author":"Werner","year":"2018","journal-title":"Eur Heart J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jcin.2018.04.017","article-title":"The IMPACTOR-CTO trial","volume":"11","author":"Obedinskiy","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"B32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ahj.2010.04.015","article-title":"Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis","volume":"160","author":"Joyal","year":"2010","journal-title":"Am Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jcin.2014.10.010","article-title":"Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation","volume":"8","author":"Jang","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"B34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0304-3959(87)90070-4","article-title":"Dorsal column stimulation for pain relief from intractable angina pectoris","volume":"28","author":"Murphy","year":"1987","journal-title":"Pain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/AJP.0000000000000435","article-title":"Spinal cord stimulation for refractory angina pectoris: a systematic review and meta-analysis","volume":"33","author":"Pan","year":"2017","journal-title":"Clin J Pain"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/AJP.0000000000000229","article-title":"Is spinal cord stimulation useful and safe for the treatment of chronic pain of ischemic origin? A review","volume":"32","author":"Kinfe","year":"2016","journal-title":"Clin J Pain"},{"key":"B37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-2796.2005.01604.x","article-title":"The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina","volume":"259","author":"Loh","year":"2006","journal-title":"J Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/s0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jacc.2006.04.094","article-title":"Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina","volume":"48","author":"Nichols","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.amjcard.2005.07.122","article-title":"Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from the international EECP patient registry)","volume":"97","author":"Soran","year":"2006","journal-title":"Am J Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.118.314118","article-title":"The impact of cell therapy on cardiovascular outcomes in patients with refractory angina","volume":"124","author":"Jones","year":"2019","journal-title":"Circ Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5648690","DOI":"10.1155\/2017\/5648690","article-title":"Cell therapy for refractory angina: a reappraisal","volume":"2017","author":"Bassetti","year":"2017","journal-title":"Stem Cells Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1001\/jama.1948.02890390014003","article-title":"Revascularization of heart by graft of systemic artery into coronary sinus","volume":"137","author":"Beck","year":"1948","journal-title":"J Am Med Assoc"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1001\/jama.1958.03000160024007","article-title":"Some new concepts of coronary heart disease; results after surgical operation","volume":"168","author":"Beck","year":"1958","journal-title":"J Am Med Assoc"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.jacc.2007.01.061","article-title":"Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study","volume":"49","author":"Banai","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijcard.2021.05.034","article-title":"Safety and efficacy of coronary sinus narrowing in chronic refractory angina: insights from the RESOURCE study","volume":"337","author":"Ponticelli","year":"2021","journal-title":"Int J Cardiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.amjcard.2020.09.045","article-title":"Usefulness of coronary sinus reducer implantation for the treatment of chronic refractory angina pectoris","volume":"139","author":"D\u2019Amico","year":"2021","journal-title":"Am J Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1540-8167.2012.02443.x","article-title":"Anatomy of the coronary sinus and epicardial coronary venous system in 620 hearts: an electrophysiology perspective","volume":"24","author":"Noheria","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e004990","DOI":"10.1161\/CIRCINTERVENTIONS.116.004990","article-title":"Effect of permanent right internal mammary artery closure on coronary collateral function and myocardial ischemia","volume":"10","author":"Stoller","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.3390\/ijms20153726","article-title":"The human coronary collateral circulation, its extracardiac anastomoses and their therapeutic promotion","volume":"20","author":"Bigler","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/s0003-4975(10)64044-1","article-title":"Noncoronary collateral myocardial blood flow","volume":"19","author":"Brazier","year":"1975","journal-title":"Ann Thorac Surg"},{"key":"B52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1874192401509010105","article-title":"Noncoronary collateral myocardial blood flow: the human heart\u2019s forgotten blood supply","volume":"9","author":"Picich\u00e8","year":"2015","journal-title":"Open Cardiovasc Med J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"61G","DOI":"10.1016\/s0002-9149(88)80034-1","article-title":"Predictors, therapeutic options and long-term outcome of abrupt reclosure","volume":"61","author":"Sinclair","year":"1988","journal-title":"Am J Cardiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mehy.2009.08.027","article-title":"Enhancement of noncoronary collateral circulation: the hypothesis of an alternative treatment for ischemic heart disease","volume":"74","author":"Picich\u00e8","year":"2010","journal-title":"Med Hypotheses"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1161\/CIRCULATIONAHA.114.008898","article-title":"Function of natural internal mammary-to-coronary artery bypasses and its effect on myocardial ischemia","volume":"129","author":"Stoller","year":"2014","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jocs.14353","article-title":"Neoangiogenesis connecting a left internal mammary artery proximal stump to an ischemic area of the heart after bypass occlusion","volume":"35","author":"Picich\u00e8","year":"2020","journal-title":"J Card Surg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.amjcard.2021.02.001","article-title":"Coronary sinus reducers and internal mammary artery occlusion: giambattista vico\u2019s recurring cycles within the history of civilization","volume":"145","author":"Picich\u00e8","year":"2021","journal-title":"Am J Cardiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.amjcard.2021.02.001","article-title":"Coronary sinus reducers and internal mammary artery occlusion: giambattista Vico's recurring cycles within the history of civilization","volume":"145","author":"Picich\u00e8","year":"2021","journal-title":"Am J Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1228201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T21:49:54Z","timestamp":1692913794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1228201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":58,"alternative-id":["10.3389\/fcvm.2023.1228201"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1228201","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"article-number":"1228201"}}